Differentiation of clinical phenotypes of inflammatory and neuropathic ocular pain conditions with morphologic measures and functional brain imaging - chronic ocular pain is a highly distressing…
Active Cooperative Agreement Awarded Last action
- Award ID
- U01EY034686
- Recipient
-
The Children's Hospital Corporation UEI Z1L9F1MM1RY3
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,704,385
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date 83% complete
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
Description
Differentiation of clinical phenotypes of inflammatory and neuropathic ocular pain conditions with morphologic measures and functional brain imaging - chronic ocular pain is a highly distressing symptom as its occurrence results in high morbidity without effective treatment. Patients with dry eye (DE) commonly have painful ocular symptoms, yet the neural mechanisms underlying this type of pain may include inflammatory (as in sjogren's syndrome) and/or neuropathic contributors (as in neuropathic ocular pain [NOP]). The cornea is innervated by the trigeminal nerve, which conveys peripheral input to the central nervous system. Using neuroimaging to evaluate peripheral nerves to supraspinal structures, we propose to define the structural and functional differences in the trigeminal circuit that differentiate inflammatory and neuropathic pain. In aim 1, we will determine trigeminal nerve pathology in persons with sjogren's VS. NOP VS. Controls using quantitative sensory testing (QST), in vivo corneal nerve microscopy (IVCM), and diffusion tensor imaging (DTI). In aim 2, we will define differences between sjogren's VS. NOP in the central nervous system by comparing functional responses to light-induced pathways associated with photophobia using fmri, and structure using MRI and DTI. This study is likely to yield (1) structural and functional diagnostic markers to differentiate inflammatory and neuropathic ocular pain with neuroimaging, and (2) evince a neurological source of pain symptoms with neuropathic ocular pain. Data generated from this investigation may be used to improve the diagnosis and monitoring of patients suffering from chronic ocular pain, and provide an objective marker to base clinical decision making.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $825,097 | |
| Amendment | $958,830 | |
| Amendment | $947,302 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $991,052 | |
| Amendment | $991,052 | |
| Original award | $991,052 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of Miami | $357,937 | |
| Massachusetts Eye And Ear Infirmary | $37,439 | |
| The General Hospital Corporation | $67,144 |
Quick answers
Who received award U01EY034686?
U01EY034686 was awarded to The Children's Hospital Corporation by National Eye Institute (National Institutes of Health) on September 30, 2022.
How much is award U01EY034686 worth?
$5,704,385 has been obligated on U01EY034686.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award